CTOs on the Move


 
Prezi`s virtual presentation, design, and video tools are the most engaging and effective way to share visual content online. Our flagship product, Prezi Video, brings your visuals on screen next to you while you present (unlike screen sharing, which hides you behind your slides). Now that we`re all connecting remotely, Prezi Video is exactly what people need for more meaningful interactions with their audience. Prezi Video works seamlessly with conferencing tools such as Zoom, Microsoft Teams, Google Meet, and Cisco Webex, and is perfect for sales pitches, business meetings, training sessions, online classes, and more. Designer templates and a massive ...
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.prezi.com
  • 450 Bryant Street
    San Francisco, CA USA 94107
  • Phone: 855.782.3550

Executives

Name Title Contact Details
Tony O`Donnell
Chief Technology Officer Profile

Similar Companies

Caso

Caso Inc. is a New York, NY-based company in the Software and Internet sector.

Egen

Egen is a data engineering, cloud modernization, and application development firm that helps companies modernize, launch, and scale industry-changing technologies.

SKALE Labs

SKALE is paving the path for the next generation of Blockchain Consensus. Decentralized Systems need greater throughput and lower transaction fees in order to meet the requirements of Decentralized Applications (dApps).

Immunome

Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.